Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the publication of Phase 1/2 ...
The Healthy @Reader's Digest on MSN
Breaking study: An experimental new drug could cut cholesterol for life
Cholesterol meds—taking by millions of Americans every day—often come with a lifelong prescription, adding out-of-pocket ...
Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
Updated Data from 31 Adult and Adolescent SCD Patients Treated with risto-cel (Formerly BEAM-101) Show Mean Hemoglobin F (HbF) Induction of ...
Exa-cel is the first FDA-approved therapy utilizing CRISPR/Cas9, a type of gene editing technology through which patients' ...
Vertex Pharmaceuticals said on Saturday its gene therapy helped children aged between 5 and 11 years with sickle cell disease ...
A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
Europe’s firewall against genetic modification gets a major crack under a new deal. Crops tailor-made using new gene-splicing techniques should face fewer regulations than genetically modified ...
Inside the station, every surface was wrapped with more of its ads—babies on turnstiles, on staircases, on banners overhead. “Think about it. Makeup and then genetic optimization,” exulted Kian ...
North America currently leads the DNA Synthesis Market due to its mature biotech ecosystem, heavy investment in genomics, and ...
The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback